Category: Clinical Breakthroughs
-
Combined Strategies Better Assess Heart Disease Risks
A new strategy combining five separate tests provided a significantly better risk assessment of cardiovascular disease among adults, compared to traditional measures, according to a study published in Circulation.
-
Cold Virus, Stem Cells Tested to Destroy Deadly Brain Cancer
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
-
Evaluating Active Surveillance in Prostate Cancer
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
-
Leaving Segregated Neighborhoods Reduces Blood Pressure for Blacks
Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
-
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
-
Comparing Quality at Veterans and Civilian Hospitals
Veterans Affairs hospitals outperformed civilian hospitals on most measures of quality and patient safety, but scored lower on indicators of patient experience, according to new Northwestern Medicine research.
-
Stopping Violence, Before It Happens
Hans Breiter, ’88 MD, professor of Psychiatry and Behavioral Sciences, is leading the development of a radical, proactive approach to stopping violence using advanced mathematical models of human emotion.
-
Evaluating Cardiovascular Health in Middle Age
A Northwestern Medicine study research shows people with no major heart disease risk factors in middle age live and stay healthy longer than others.
-
Pinpointing Cost-Effective Diagnostics for a Common Urological Condition
A combination of ultrasound and cystoscopy is the most cost-effective approach to detecting cancer in patients who show microscopic amounts of blood in their urine, according to a JAMA Internal Medicine study.
-
Pioneering Precision Medicine in Cancer
OncoSET, the flagship clinical and research program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, combines oncology with genomic sequencing to provide cutting-edge cancer care personalized for each patient.
